DJIA 17,757.91 0.00 0.00%
NASDAQ 5,013.12 0.00 0.00%
S&P 500 2,077.42 0.00 0.00%
market minute promo

41.69 0.02 (0.05%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACAD $41.69 0.05%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $42.42
Previous Close $41.67
Daily Range $41.22 - $42.48
52-Week Range $19.21 - $46.48
Market Cap $4.2B
P/E Ratio -36.10
Dividend (Yield) $0.00 (0.0%)
Volume 775,238
Average Daily Volume 962,127
Current FY EPS -$1.35

Sector

Healthcare

Industry

Drug Makers

ACADIA Pharmaceuticals, Inc. (ACAD) Description

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Website: http://www.acadia-pharm.com/

News & Commentary Rss Feed

3 Common Pitfalls Biotech Investors Need to Learn to Avoid

Here is a look at three common mistakes investors make when buying biotech stocks.

Insiders Love These 3 Biotech Stocks

These three biotech stocks have big inside ownership, which means their management has a lot of financial incentive to make the company succeed.

Andreas Halvorsen Increases Stake in Esperion Therapeutics

ACADIA Pharmaceuticals Is Poised To Outperform The IBB Moving Forward

Seeking Alpha's Biotech Weekly: Bubble Trouble, Allergan's Kythera Takeout, And More

My Advice For Young Traders To Successfully Navigate The Market

The Zacks Analyst Blog Highlights: Johnson & Johnson, AstraZeneca, ACADIA Pharmaceuticals, Actavis a

The Zacks Analyst Blog Highlights: Johnson & Johnson, AstraZeneca, ACADIA Pharmaceuticals, Actavis and Alkermes - Press Releases

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update

Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter

Acadia Pharmaceuticals Moves Up In Market Cap Rank, Passing QEP Resources

See More ACAD News...

ACAD's Top Competitors

ACAD $41.69 (0.05%)
Current stock: ACAD
AMGN $155.41 (0.27%)
Current stock: AMGN
GILD $116.23 (0.19%)
Current stock: GILD
BIIB $406.42 (0.25%)
Current stock: BIIB